CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

SK Biopharmaceuticals announced that it submitted a new drug application to the US Food and Drug Administration for the oral ...

Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has granted a five-year exemption from price ...

Elite Pharmaceuticals ( (ELTP) ) has shared an update.

This Study explores several new DehydraTECH enhancements not previously evaluated, which include but are not limited to the ...

After Eli Lilly achieved the milestone approval of the weight loss pill Foundayo, Novo Nordisk launched a full-court press to ...

World’s first dispersible tablets of Lasmiditan, designed to deliver rapid migraine relief by selectively targeting a ...

Eli Lilly announced this morning that the FDA has, as was expected, approved its oral GLP-1, orforglipron, as treatment for ...

Food does not affect Foundayo, so it can be taken with or without food. In contrast, oral Wegovy has to be taken on an empty ...

Novo Nordisk stock jumps after launching a Wegovy subscription plan to cut costs, expand telehealth access and improve ...

The Microcrystalline Cellulose Market size was estimated at USD 1.30 billion in 2025 and is expected to reach USD 2.61 billion by 2035, growing at a CAGR of 7.23% over the forecast period (2026-2035).

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...